The EUFEMED conference spotlights exploratory development of novel therapeutic approaches – lessons learned in the pandemic. Join regulators, sponsors and CROs to hear how the industry has overcome the challenge of conducting clinical research during a global pandemic.

Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.

Join the conversation and register on the EUFEMED website.

You can read how Richmond Pharmacology responded to the pandemic in our article in PM Live.

Latest news

Clinical trials: how taking the pills can pay those bills.

April 20, 2022
The Guardian references Richmond Pharmacology in feature on reimbursement for clinical trial volunteers
Read more

Clinical trials and the patient perspective

May 6, 2022
Successful recruitment and retention of patients - an essential element to delivering clinical studies on time.
Read more


The Future of Healthcare - March 2022

13:30 – 16:00, 22nd March 2022
Discover the intricacies of assessing abnormal liver functions in clinical trial volunteers and gain insights from the latest drug development trials using RNAi therapeutics.
View event